| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |